Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date: May 14, 2020
Context: The filing serves as a Regulation FD disclosure to distribute a slide presentation provided during the Company's quarterly earnings call. The presentation is attached as Exhibit 99.1 and is incorporated by reference.
Key Financial Metrics
The provided text does not contain specific financial data. This Form 8-K acts as a conduit for a slide presentation rather than a direct report of financial statements. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document.
Material Changes
No material changes to financial position or operations are detailed within the text of this filing. The document solely references the availability of an update via a slide presentation.
Guidance, Outlook, and Risks
Management Commentary: The Company provided an update via a slide presentation during its quarterly earnings call on May 14, 2020.
Legal Disclaimer: The information contained in this Form 8-K and the attached exhibit is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act. It is not subject to the liabilities of that section and shall not be incorporated by reference into any filing under the Securities Act or Exchange Act, except as expressly set forth by specific reference.
Risks/Contingencies: No specific risks or contingencies are listed in the text of this filing.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (slide presentation) for actual financial figures and operational updates.
- Verify the content of the slide presentation on the Company's website at www.capricor.com under the "Investors" section.
- Confirm that the slide presentation is not considered "filed" for liability purposes under Section 18 of the Exchange Act.